• Home
  • NEW DAY MEDICINE
  • 3 (35) 2021
  • 46 -3 (35) 2021 — Sapaeva Z.A., Jabbarov O.O. — THE IMPORTANCE OF HEMODYNAMIC FACTORS IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY

46 -3 (35) 2021 — Sapaeva Z.A., Jabbarov O.O. — THE IMPORTANCE OF HEMODYNAMIC FACTORS IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY

THE IMPORTANCE OF HEMODYNAMIC FACTORS IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY 

Sapaeva Z.A., Urgench branch of Tashkent medical academy Tashkent medical academy

Jabbarov O.O. Urgench branch of Tashkent medical academy Tashkent medical academy

Resume

This article presents current data on the basic mechanisms of development and progression of diabetic nephropathy (DN), which are the same for both types of diabetes mellitus (DM). Diabetic nephropathy results from the interaction of various factors (metabolic, hemodynamic, neurogenic, and toxic ones) in a genetically predisposed diabetic patient. This manuscript reviews the role of hemodynamic factors in the development of diabetic nephropathy. First, the role of glomerular blood pressure changes is described, together with different factors that may influence it in different mechanisms.

Key words: diabetes, diabetic nephropathy, microalbuminuria, hyperglycemia, dyslipidemia

First page

238

Last page

241

For citation: Sapaeva Z.A., Jabbarov O.O. THE IMPORTANCE OF HEMODYNAMIC FACTORS IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY //New Day in Medicine 3(35)2021 238-241 https://cutt.ly/gEjb6LF

LIST OF REFERENCES:

  1. Andreev I.L., Nazarova L.I. Bitter diabetes mellitus. //RAS Bulletin 2014; 84 (2): 1705.
  2. Ansari NA, Rashid Z. Non-enzymatic glycation of proteins: from diabetes to cancer. //Biomedical Chemistry. 2010; 56 (2): 168–78.
  3. Baranov A.A., Namazova-Baranova L.S., Ilyin A.G., Bulgakova V.A., Antonova E.V., Smirnov I.E. Scientific research in pediatrics: directions, achievements, prospects. //Russian Pediatric Journal. 2013; 5: 4-14.
  4. Bondar I.A., Klimontov V.V. Early markers of diabetic nephropathy. //Clinical Nephrology. 2010; 2: 60-5.
  5. Dedov I.I., Kuraeva T.L., Peterkova V.A. Diabetes mellitus in children and adolescents. /M .: GEOTAR-Media; 2007.
  6. Zakharyina O.A., Tarasov A.A., Babaeva A.R. Actual aspects of drug prevention and treatment of diabetic angiopathy. //Medicinal Herald. 2012; 6 (5): 14-22.
  7. Lebedeva N.O., Vikulova O.K. Markers of preclinical diagnosis of diabetic nephropathy in patients with type 2 diabetes mellitus. //Diabetes. 2012; 2: 38-45.
  8. Parfenova E.V., Tkachuk V.A. The effect of hyperglycemia on the angiogenic properties of vascular endothelial and progenitor cells. //Bulletin of the RAMS. 2012; 1: 38-44.
  9. Diabetes mellitus: diagnosis, treatment, prevention / Under. ed. I.I. Dedova, M.V. Shestakova. //Medical News Agency; 2011.
  10. Shestakova M.V. Diabetes mellitus and chronic kidney disease: modern diagnosis and treatment. //Bulletin of the Russian Academy of Medical Sciences. 2012; 1: 45-9.
  11. Shestakova MV, Chugunova LA, Shamkhalova M.Sh., Dedov II Diabetic nephropathy: advances in diagnosis, prevention, treatment. //Diabetes. 2005; 3: 22-4.
  12. Araki S., Haneda M., Sugimoto T., Isono M., Isshiki K., Kashiwagi A., Koya D. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. //Diabetes. 2005; 54 (10): 2983-7.
  13. Cherney D.Z., Scholey J.W., Daneman D., Dunger D.B., Dalton R.N., Moineddin R.et al. Urinary markers of renal inflammation in adolescents with Type 2 diabetes mellitus and normo albuminuria. //Diabet. Med. 2012; 29 (10): 1297-302.
  14. Demirel F., Tepe D., Kara O., Esen I. Microvascular complications in adolescents with type 2 diabetes mellitus. //J. Clin. Res. Pediatr. Endocrinol. 2013; 5 (3): 145-9.
  15. Diez-Sampedro A., Lenz O., Fornoni A. Podocytopathy in diabetes: a metabolic and endocrine disorder. //Am. J. Kidney Dis. 2011; 58 (4): 637 46.
  16. Forbes J.M., Fukami K., Cooper M.E. Diabetic nephropathy: where hemodynamics meets metabolism. //Exp. Clin. Endocrinol.Diabet. 2007; 115 (2): 69–84.
  17. Gaede P., Tarnow L., Vedel P., Parving H.H., Pedersen O. Remission to normo albuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. //Nephrol. Dial. Transplant. 2004; 19 (11): 2784-8.
  18. Gu H.F., Brismar K. Genetic association studies in diabetic nephropathy. //Curr. Diabet.Rev. 2012; 8 (5): 336–44.
  19. Hidalgo F. J., Zamora R. Interplay between the maillard reaction and lipid peroxidation in biochemical systems. //Ann. N. Y. Acad. Sci. 2005; 1043: 319-26.
  20. Otu H.H., Can H., Spentzos D., Nelson R.G., Hanson R.L., Looker H.C. Prediction of diabetic nephropathy using urine proteomic pro-13 (4): 560 6.

file

download